Pharma Asia | Top StoriesCopyright 2007 Reed Business Information, a division of Reed Elsevier Inc. All rights reserved.Geron has received a license to Stemcell Technologies under Geron intellectual property relating to primate pluripotent stem cells, including human embryonic stem cells. The non-exclusive license provides ...http://www.pharmaasia.com/article-6973-stemcelltechnologiesinclicensesgeronintellectualpropertytodevelopmediaandmatricesforstemcellgrowth-Asia.htmlIndiPharm has announced that James A. Bannon, former Group President, Late Stage Development Services, Covance, Inc., has joined IndiPharm as Executive Chairman. Prior to 2005, Bannon led and was responsible ...http://www.pharmaasia.com/article-6944-indipharmnewexecutivechairman-Asia.htmlChina’s Benda Pharmaceutical, Inc says its subsidiary, Jiangling Benda Pharmaceutical Co., Ltd., has received the Good Manufacturing Practice (GMP) certificate by the Chinese State Food and Drug Administration ...http://www.pharmaasia.com/article-6942-jianglingbendapharmaceuticalgmpcertified-Asia.htmlBilcare Global Clinical Supplies, a leading single-source provider of clinical trial services, has formed its first corporate Advisory Board. Bilcare Limited’s chairman and managing director Mohan Bhandari ...http://www.pharmaasia.com/article-6940-bilcareglobalclinicalsuppliesformscorporateadvisoryboard-Asia.htmlMultisorb Technologies says it has partnered with Neutroplast Indústria de Embalagens Plásticas, S.A to offer a Multiform Coated Solid Form (CSF) Closure System for high-density polyethylene (HDPE) ...http://www.pharmaasia.com/article-6939-newdesiccantclosuresystemforhdpepharmaceuticalbottles-Asia.htmlDr Reddy’s Laboratories announced it has signed a definitive agreement to acquire BASF’s pharmaceutical contract manufacturing business and related facility in Shreveport, Louisiana, US. This transaction ...http://www.pharmaasia.com/article-6937-drreddysacquiresbasfspharmaceuticalcontractmanufacturingbusiness-Asia.htmlResearch organizations around the world announced today that they are launching the International Cancer Genome Consortium (ICGC), a collaboration designed to generate high-quality genomic data on up ...http://www.pharmaasia.com/article-6934-scientistsforminternationalcancergenomeconsortium-Asia.htmlAstraZeneca has announced submission of a supplemental New Drug Application (sNDA) to the US Food and Drug Administration (FDA) to seek approval of a new indication for SYMBICORT (budesonide/formoterol ...http://www.pharmaasia.com/article-6933-astrazenecasubmitssndaforsymbicortforcopdtreatment-Asia.htmlCounterfeit drug sales are estimated to reach $75 billion by 2010, says the World Health Organisation (WHO). However, there is too much talk and not enough decisive action being taken in the industry ...http://www.pharmaasia.com/article-6931-counterfeitdrugsdecisiveandglobalactionisneeded-Asia.htmlSenator Kim Carr, Minister for Innovation, Industry, Science and Research announced the Australian Government would provide AUD$7 million ($6.54 million) for new collaborative science initiatives under ...http://www.pharmaasia.com/article-6930-australiaindiatostrengthenties-Asia.html